Supreme Pharma Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 32.74%
(FY 2020)
- Ebitda 32.74%
(FY 2020)
- Net Worth -14.98%
(FY 2020)
- Total Assets 63.98%
(FY 2020)
About Supreme Pharma Healthcare
The Corporate was formerly known as Supreme Suppliers Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayesh Vora and Falguni Prataprai serve as directors at the Company.
- CIN/LLPIN
U74999MH2013PTC242630
- Company No.
242630
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Supreme Pharma Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Falguni Prataprai  | Director | 01-Dec-2017 | Current |
| Jayesh Vora | Director | 29-Apr-2013 | Current |
Financial Performance of Supreme Pharma Healthcare.
Supreme Pharma Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supreme Pharma Healthcare?
In 2020, Supreme Pharma Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trebro India Hospitality Private LimitedActive 9 years 1 monthJayesh Vora and Falguni Prataprai are mutual person
Jae Pharmacy Private LimitedActive 21 years 1 monthJayesh Vora and Falguni Prataprai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Supreme Pharma Healthcare?
Unlock and access historical data on people associated with Supreme Pharma Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supreme Pharma Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supreme Pharma Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
